These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22290263)

  • 21. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On glioblastoma and the search for a cure: where do we stand?
    Bianco J; Bastiancich C; Jankovski A; des Rieux A; Préat V; Danhier F
    Cell Mol Life Sci; 2017 Jul; 74(13):2451-2466. PubMed ID: 28210785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioblastoma heterogeneity and cancer cell plasticity.
    Friedmann-Morvinski D
    Crit Rev Oncog; 2014; 19(5):327-36. PubMed ID: 25404148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy.
    Spencer DA; Auffinger BM; Murphy JP; Muroski ME; Qiao J; Gorind Y; Lesniak MS
    Curr Cancer Drug Targets; 2017; 17(3):236-254. PubMed ID: 27993114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication.
    Iwadate Y
    Neurol Med Chir (Tokyo); 2018 Feb; 58(2):61-70. PubMed ID: 29129882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.
    Visnyei K; Onodera H; Damoiseaux R; Saigusa K; Petrosyan S; De Vries D; Ferrari D; Saxe J; Panosyan EH; Masterman-Smith M; Mottahedeh J; Bradley KA; Huang J; Sabatti C; Nakano I; Kornblum HI
    Mol Cancer Ther; 2011 Oct; 10(10):1818-28. PubMed ID: 21859839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and Culture of Glioblastoma Brain Tumor Stem Cells.
    Chesnelong C; Restall I; Weiss S
    Methods Mol Biol; 2019; 1869():11-21. PubMed ID: 30324510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
    Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
    J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
    Mukherjee S
    Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting.
    Vieira de Castro J; Gonçalves CS; Hormigo A; Costa BM
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioblastoma, cancer stem cells and hypoxia.
    Bar EE
    Brain Pathol; 2011 Mar; 21(2):119-29. PubMed ID: 21054626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.
    Kim HJ; Kim DY
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33053763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
    van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
    Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells.
    Hu Z; Zhou T; Wu F; Lin F
    J Vis Exp; 2021 Mar; (169):. PubMed ID: 33843936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BMI1 sustains human glioblastoma multiforme stem cell renewal.
    Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
    J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesis.
    Kast RE; Belda-Iniesta C
    Curr Stem Cell Res Ther; 2009 Dec; 4(4):314-7. PubMed ID: 19500061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.